Skip to content
healthcare.dev

DEXTROMETHORPHAN POLISTIREX

NDC 11673-033, DEXTROMETHORPHAN POLISTIREX, suspension, extended release, from Target Corporation.

Product NDC
11673-033
Status
Listed
Labeler
Target Corporation
Dosage form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA218417
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-033 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN30 mg/5mL

Pharmacologic classes

Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
11673-033-05116730033051 BOTTLE in 1 CARTON (11673-033-05) / 148 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-033 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-033 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-033. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.